Skip to main content

Table 4 GSRS and GIQLI scores by physician's rating of clinical disease severity at baseline

From: Gastrointestinal (GI)-Specific patient reported outcomes instruments differentiate between renal transplant patients with or without GI symptoms: results from a South American cohort

 

Groups by rating of clinical severity

Kruskall-Wallis

Test of overall differences

 

Patient reported outcome

instrument and domain

None (n = 20)

mean (SD)

Mild (n = 6)

mean (SD)

Moderate (n = 32)

mean (SD)

Severe (n = 4)

mean (SD)

Chi-Square

p-value

Wilcoxon

rank-sum tests

(pairwise

comparisons

with p < 0.001)

GSRS Abdominal Pain

1.33 (0.42)

2.61 (0.93)

3.29 (1.23)

3.83 (1.69)

33.75

<0.001

b

GSRS Reflux Syndrome

1.10 (0.26)

2.42 (1.32)

3.09 (1.46)

4.00 (2.12)

29.25

<0.001

b, c

GSRS Diarrhea

1.12 (0.20)

3.61 (1.69)

3.57 (1.56)

2.67 (1.70)

37.21

<0.001

a, b

GSRS Indigestion Syndrome

1.29 (0.33)

3.29 (1.81)

3.76 (1.43)

4.81 (1.68)

38.29

<0.001

a, b

GSRS Constipation

1.20 (0.38)

1.94 (0.65)

2.55 (1.26)

3.42 (2.23)

27.03

<0.001

b

GIQLI Total Score

126.00 (10.97)

95.83 (23.22)

87.02 (22.08)

65.00 (37.37)

33.25

<0.001

b

GIQLI Symptoms

3.64 (0.30)

2.65 (0.68)

2.49 (0.57)

1.87 (0.82)

35.31

<0.001

b

GIQLI Emotion

3.24 (0.64)

2.87 (0.70)

2.47 (0.74)

1.60 (0.86)

16.33

<0.001

 

GIQLI Physical Function

3.21 (0.61)

2.14 (0.89)

1.92 (0.91)

1.61 (1.62)

22.00

<0.001

b

GIQLI Social Function

3.55 (0.60)

3.04 (0.70)

2.74 (0.96)

2.19 (1.60)

10.22

0.017

 

GIQLI Medical Treatment

3.95 (0.22)

4.00 (0.00)

2.94 (1.11)

1.50 (1.91)

21.25

<0.001

b, c

  1. Comparisons not significant unless noted.
  2. a = none vs. mild; b = none vs. moderate; c = none vs. severe;
  3. d = mild vs. moderate; e = mild vs. severe; f = moderate vs. severe.